Build or Inherit: Leading Biotech Medical Affairs from Clinical Trials to Commercialization
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
What happens when a biotech company waits too long to build the Medical Affairs capabilities it needs for a successful launch?
Building a Medical Affairs organization is challenging. Transforming an existing team to meet the demands of commercialization can be even harder.
In this episode of Medical Affairs Unscripted, host Peg Crowley-Nowick speaks with Kelly Covello, Head of Medical at RayzeBio, about what it takes to build, lead, and scale Medical Affairs in a growing biotech company.
Kelly brings a rare perspective: she has built a Medical Affairs function from the ground up, supported clinical development through a company's first product launch and acquisition, and subsequently taken on the challenge of evolving an established team toward commercialization.
Drawing on these experiences, Kelly shares practical lessons for biotech and Medical Affairs leaders:
· Build or inherit? Why transforming an established team can be more challenging than starting from scratch.
· Start before launch. Why Medical Affairs capabilities, evidence generation, and external engagement must evolve alongside clinical development—not wait for regulatory approval.
· Hire for the future. How to build versatile teams, manage organizational change, and scale resources around critical development milestones.
· Demonstrate strategic value. How investigator-sponsored research, medical insights, and evidence planning can influence development decisions, clinical practice, and patient access.
· Become a strategic partner. Why Medical Affairs must work across clinical development and commercial functions rather than operate as a service organization.
The conversation also explores the often-overlooked realities of biotech leadership: resource constraints, the importance of medical directors, and the role of external partners in building an effective organization.
Whether you're building a biotech company, preparing for your first product launch, or leading a Medical Affairs team through change, this episode offers practical insights from someone who has navigated both sides of the journey.